Signalc719fe86

WEBINDEXED

Pharmaceutical Research and Manufacturers of America spent $28.9 million lobbying Congress in Q2 2023 ahead of Senate votes on drug pricing provisions in the Inflation Reduction Act.

Author:opensecrets.org

Published:2023-07-20 00:00 UTC

Occurred:2023-06-30 00:00 UTC

Received:2026-05-31 08:00 UTC

Status Score

88%

ITG

90%

IMP

80%

NAR

55%

Analysis Insights

Topics Detected

#Lobbying Disclosures#Drug Pricing

Entities Mentioned

@PhRMA@Senate@Inflation Reduction Act

Technical Details

Analyst Mission

Corporate Lobbying Trackera76754d3...

Source IDN/A

Original URLhttps://www.opensecrets.org

Database IDc719fe86-54fc-44b6-b4d1-c4e35d44ac09

Raw Data

{
  "id": "c719fe86-54fc-44b6-b4d1-c4e35d44ac09",
  "content": "Pharmaceutical Research and Manufacturers of America spent $28.9 million lobbying Congress in Q2 2023 ahead of Senate votes on drug pricing provisions in the Inflation Reduction Act.",
  "url": "https://www.opensecrets.org",
  "source_type": "web",
  "source_id": null,
  "author_id": "opensecrets.org",
  "published_at": "2023-07-20T00:00:00.000Z",
  "received_at": "2026-05-31T08:00:21.719Z",
  "status": "indexed",
  "relevance_score": 88,
  "case_id": null,
  "metadata": {
    "topics": [
      "Lobbying Disclosures",
      "Drug Pricing"
    ],
    "mission": "Corporate Lobbying Tracker",
    "mentions": [
      "PhRMA",
      "Senate",
      "Inflation Reduction Act"
    ],
    "mission_id": "a76754d3-444f-44d8-bf31-a548a575182e"
  },
  "credibility_score": 90,
  "actionability_score": 80,
  "emotional_score": 55,
  "occurred_at": "2023-06-30T00:00:00.000Z",
  "case_ids": null
}